Your new post is loading...
Forbes
With So Many Terrific New Drugs For Chronic Lymphocytic Leukemia, Why Worry?
Forbes
It's hard to keep track of practice-changing drugs for chronic lymphocytic leukemia (CLL).
|
Scooped by Alfredo Corell |
Scoop.it!
No comment yet.
Sign up to comment
It’s hard to keep track of practice-changing drugs for chronic lymphocytic leukemia (CLL). Since last November, the FDA has approved three new agents and expanded indications for another to treat this indolent cancer of white blood cells. As someone who spent over ten years studying this form of leukemia, I’m thrilled by the science behind these targeted medicines, and by the potentially life-saving new options for people with this condition.